114 related articles for article (PubMed ID: 2514185)
1. Antimicrobial peptides, isolated from horseshoe crab hemocytes, tachyplesin II, and polyphemusins I and II: chemical structures and biological activity.
Miyata T; Tokunaga F; Yoneya T; Yoshikawa K; Iwanaga S; Niwa M; Takao T; Shimonishi Y
J Biochem; 1989 Oct; 106(4):663-8. PubMed ID: 2514185
[TBL] [Abstract][Full Text] [Related]
2. Modified horseshoe crab peptides target and kill bacteria inside host cells.
Amiss AS; von Pein JB; Webb JR; Condon ND; Harvey PJ; Phan MD; Schembri MA; Currie BJ; Sweet MJ; Craik DJ; Kapetanovic R; Henriques ST; Lawrence N
Cell Mol Life Sci; 2021 Dec; 79(1):38. PubMed ID: 34971427
[TBL] [Abstract][Full Text] [Related]
3. pDNA-tachyplesin treatment stimulates the immune system and increases the probability of apoptosis in MC4-L2 tumor cells.
Mahmoudi-Filabadi F; Doosti A
Amino Acids; 2024 May; 56(1):34. PubMed ID: 38691208
[TBL] [Abstract][Full Text] [Related]
4. Primary structure and cellular localization of callinectin, an antimicrobial peptide from the blue crab.
Noga EJ; Stone KL; Wood A; Gordon WL; Robinette D
Dev Comp Immunol; 2011 Apr; 35(4):409-15. PubMed ID: 21115038
[TBL] [Abstract][Full Text] [Related]
5. Tachyplesin, a class of antimicrobial peptide from the hemocytes of the horseshoe crab (Tachypleus tridentatus). Isolation and chemical structure.
Nakamura T; Furunaka H; Miyata T; Tokunaga F; Muta T; Iwanaga S; Niwa M; Takao T; Shimonishi Y
J Biol Chem; 1988 Nov; 263(32):16709-13. PubMed ID: 3141410
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of tachyplesin I injury to bacterial membranes and intracellular enzymes, determined by laser confocal scanning microscopy and flow cytometry.
Hong J; Guan W; Jin G; Zhao H; Jiang X; Dai J
Microbiol Res; 2015 Jan; 170():69-77. PubMed ID: 25267486
[TBL] [Abstract][Full Text] [Related]
7. Protegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity.
Steinberg DA; Hurst MA; Fujii CA; Kung AH; Ho JF; Cheng FC; Loury DJ; Fiddes JC
Antimicrob Agents Chemother; 1997 Aug; 41(8):1738-42. PubMed ID: 9257752
[TBL] [Abstract][Full Text] [Related]
8. Protegrins: leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins.
Kokryakov VN; Harwig SS; Panyutich EA; Shevchenko AA; Aleshina GM; Shamova OV; Korneva HA; Lehrer RI
FEBS Lett; 1993 Jul; 327(2):231-6. PubMed ID: 8335113
[TBL] [Abstract][Full Text] [Related]
9. Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.
Edwards IA; Elliott AG; Kavanagh AM; Blaskovich MAT; Cooper MA
ACS Infect Dis; 2017 Dec; 3(12):917-926. PubMed ID: 28960954
[TBL] [Abstract][Full Text] [Related]
10. Contribution of Amphipathicity and Hydrophobicity to the Antimicrobial Activity and Cytotoxicity of β-Hairpin Peptides.
Edwards IA; Elliott AG; Kavanagh AM; Zuegg J; Blaskovich MA; Cooper MA
ACS Infect Dis; 2016 Jun; 2(6):442-450. PubMed ID: 27331141
[TBL] [Abstract][Full Text] [Related]
11. Structure-function relationships of tachyplesins and their analogues.
Iwanaga S; Muta T; Shigenaga T; Seki N; Kawano K; Katsu T; Kawabata S
Ciba Found Symp; 1994; 186():160-74; discussion 174-5. PubMed ID: 7768150
[TBL] [Abstract][Full Text] [Related]
12. Signaling by two-component system noncognate partners promotes intrinsic tolerance to polymyxin B in uropathogenic Escherichia coli.
Guckes KR; Breland EJ; Zhang EW; Hanks SC; Gill NK; Algood HM; Schmitz JE; Stratton CW; Hadjifrangiskou M
Sci Signal; 2017 Jan; 10(461):. PubMed ID: 28074004
[TBL] [Abstract][Full Text] [Related]
13. Propelling Immunotherapy Combinations Into the Clinic.
Tchekmedyian N; Gray JE; Creelan BC; Chiappori AA; Beg AA; Soliman H; Perez BA; Antonia SJ
Oncology (Williston Park); 2015 Dec; 29(12):990-1002. PubMed ID: 26680224
[TBL] [Abstract][Full Text] [Related]
14. In vivo assessment of 6-deoxy-6-[18F]fluoro-D-galactose as a PET tracer for studying galactose metabolism.
Ishiwata K; Tomura M; Ido T; Iwata R; Itoh J; Kameyama M
Int J Rad Appl Instrum B; 1989; 16(8):775-81. PubMed ID: 2621112
[TBL] [Abstract][Full Text] [Related]
15. Quantitative Proteomic Profiling of Tachyplesin I Targets in U251 Gliomaspheres.
Li X; Dai J; Tang Y; Li L; Jin G
Mar Drugs; 2017 Jan; 15(1):. PubMed ID: 28106765
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial resistance crisis: could artificial intelligence be the solution?
Liu GY; Yu D; Fan MM; Zhang X; Jin ZY; Tang C; Liu XF
Mil Med Res; 2024 Jan; 11(1):7. PubMed ID: 38254241
[TBL] [Abstract][Full Text] [Related]
17. Development of a Novel Peptide with Antimicrobial and Mineralising Properties for Caries Management.
Zhang OL; Niu JY; Yu OY; Mei ML; Jakubovics NS; Chu CH
Pharmaceutics; 2023 Oct; 15(11):. PubMed ID: 38004539
[TBL] [Abstract][Full Text] [Related]
18. Host Defense Proteins and Peptides with Lipopolysaccharide-Binding Activity from Marine Invertebrates and Their Therapeutic Potential in Gram-Negative Sepsis.
Solov'eva TF; Bakholdina SI; Naberezhnykh GA
Mar Drugs; 2023 Nov; 21(11):. PubMed ID: 37999405
[TBL] [Abstract][Full Text] [Related]
19. Marine Invertebrate Antimicrobial Peptides and Their Potential as Novel Peptide Antibiotics.
Guryanova SV; Balandin SV; Belogurova-Ovchinnikova OY; Ovchinnikova TV
Mar Drugs; 2023 Sep; 21(10):. PubMed ID: 37888438
[TBL] [Abstract][Full Text] [Related]
20. Adapting antibacterial display to identify serum-active macrocyclic peptide antibiotics.
Randall JR; Groover KE; O'Donnell AC; Garza JM; Cole TJ; Davies BW
PNAS Nexus; 2023 Aug; 2(8):pgad270. PubMed ID: 37637199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
